Skip to main content

Current Funding Announcements

See below

Defense Health Program (DHP) Military Operational Medicine Research Program (MOMRP) Joint Program Committee-5 (JPC-5) Intramural funding opportunity annoncement

W81XWH-22-MOMRP-D: Defense Health Program (DHP) Military Operational Medicine Research Program 
(MOMRP) Joint Program Committee-5 (JPC-5) Intramural Funding Opportunity Announcement
 
Description: This solicitation requests intramural applications for the Fiscal Year 2022 (FY22) US 
Army Medical Research and Development Command’s (USAMRDC’s) Military Operational Medicine Research 
Program (MOMRP)/Joint Program Committee-5 (JPC-5).
 
The MOMRP/JPC-5 mission is to develop effective biomedical countermeasures against operational 
stressors and prevent physical and psychological injuries during training and operations in order 
to maximize the health, readiness and performance of Service members in Multi-Domain Operations and 
in support of Army Holistic Health and Fitness, Human Performance Optimization and Enhancement, 
Army Cross Functional Team Priorities, Human Dimension, and the Department of Defense (DoD) Total 
Force Fitness concepts.
 
To be considered for funding, proposed research must align to one of the FY22 JPC-5 Goals and 
Objectives, which include goals in Sensory Protection and Treatment:
 
•    Goal 1: Joint DoD medical protection and performance criteria for hearing protection devices 
(HPDs) to reduce injury risk and improve use of HPDs by Service members in multi-domain operations.
 
•    Goal 2: Treatment mitigation solutions for acute and chronic sensory dysfunction (auditory, 
visual, and balance dysfunction).
 
•    Goal 3: Tools to monitor and provide intervention capabilities that will prevent/mitigate 
hearing loss and tinnitus from hazardous noise exposure.
 
Submission is a two-step process requiring both pre-application submission and full application
submission through eBRAP (https://eBRAP.org/).
 
Pre-app due: 1 December 2020
Invitations for Full Application Submission: NLT December 21, 2020
Full app due: 9 February 2021
Max Period of Performance: 3 years
Budget: anticipated total (direct and indirect) costs budgeted per year has averaged approximately 
$350K per project.
 
To download the solicitation and begin pre-application, applicants should direct their internet 
browser first to eBRAP (https://ebrap.org) and once there, either login or register through the 
Register tab. Once logged into eBRAP, use this link to find the FY22 solicitation application page: 
 

Hearing Health Foundation (HHF)'s 2021 Emerging Research Grants (ERG)

Hearing Health Foundation (HHF)'s 2021 Emerging Research Grants (ERG)

 
DESCRIPTION: Through the Emerging Research Grants (ERG) program, Hearing Health Foundation (HHF) 
provides seed money to researchers working on the entire spectrum of hearing research and balance 
research, including many underfunded areas of otology.
 
The General Hearing Health grant opportunity supports projects across the broadest spectrum of 
hearing research and balance research, from improving audiological assessments and cochlear 
implants to gene editing, ototoxicity, sensory cues in maintaining postural balance, and links 
between hearing and other health issues, such as cardiovascular disease and diabetes.
 
There are also dedicated disorder-specific grant opportunities for:
 
•     Age-Related Hearing Loss (New for 2020)
•     Central Auditory Processing Disorder
•     General Hearing Health (Restricted to Early Career Researchers)
•     Hearing Loss in Children
•     Hyperacusis
•     Ménière's Disease
•     Tinnitus
•     Usher Syndrome
 
APPLICATIONS OPEN
November 2, 2020
APPLICATION DEADLINE
February 25, 2021
FUNDING
Up to $50,000 per year, one year in length in the first instance, and renewable for a second year.
 
 

Open/active nih funding opportunities

  PAR-18-533: NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trial Optional)

Posted December 2017, expires February 23, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-18-533.html

The objective of this funding opportunity announcement (FOA) is to provide support for research studies that translate basic research findings into better clinical tools for human health. The application should seek to translate basic behavioral or biological research findings, which are known to be directly connected to a human clinical condition, to a practical clinical impact. Tools or technologies advanced through this FOA must overcome existing obstacles and should provide improvements in the diagnosis, treatment, or prevention of a disease process. For the purposes of this FOA, the basic science advancement must have previously demonstrated potential for clinical impact and the connection to a human clinical condition must be clearly established. The scope of this FOA allows for a range of activities encouraging the translation of basic research findings to practical impact on the diagnosis, treatment and prevention of deafness and other communication disorders. This FOA is not intended for outcomes/health services research, the extension of ongoing clinical studies, the optimization of current clinical protocols, or

pre-translational studies (early stage proof of concept or developmental work premature to direct clinical relevance). Basic discovery research is not appropriate under this FOA.

PAR-19-159: Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

  Posted January 2019, expires May 8, 2021

  https://grants.nih.gov/grants/guide/pa-files/PAR-19-159.html

Participating NIH component organizations include: NIBIB and NINDS

 The goal for a bioengineering research grant (BRG) is to foster the development of an innovative technology, model, technique, design,           or method that has the potential for significant impact on biomedical research by infusing principles and concepts from the quantitative           sciences. The purpose of this FOA is to encourage BRG applications that: 1) apply a multidisciplinary approach to the solution of a                   biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods               and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. Significant projects may           include, but are not limited to: validation and translation of promising tools for prevention, monitoring or intervention; development of             quantitative, predictive models of complex biological systems; integration and optimization of technologies that significantly increase  sensitivity, specificity, positive predictive value, negative predictive value, efficiency, or throughput of measurements to address                     unsolved biological or medical questions; or engineering and testing of delivery systems, tissues, therapeutics, implants, and prosthetics           that may improve treatment and healthcare.

RFA-DC-19-001: NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)

Posted July 2018, expires June 5, 2021

    https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-19-001.html

This FOA requests research to increase accessible and affordable hearing health care (HHC). In this context, HHC refers broadly not only to hearing technology but also to the systematic and comprehensive hearing-related services involved in diagnosis, treatment, auditory rehabilitation, and counseling of individuals with hearing loss, as well as other services that collectively allow the individual to maximize his or her communication outcomes. The purpose of this FOA is to encourage research and increase infrastructure support leading to accessible and affordable hearing health care and improved outcomes. This includes research on the development of technologies (e.g., low-cost hearing aids, NIDCD open speech signal processing tools), screening (e.g., effectiveness in typical primary care settings), access and management through new delivery systems (e.g., telehealth, internet, kiosk, convenient care clinics), system barriers (e.g., availability of services, cost, location, insurance coverage, referral network) as well as behavioral research at the individual patient level (e.g., variables influencing one’s perceived need for HHC, patient outcomes). Solutions should be implementable and sustainable in settings

Open/Active DoD Broad Agency Announcements

U.S. Army Medical Research and Development Command (USAMRDC) - W81XWH18SBAA1: This BAA is open through September 30, 2022. USAMRDC funds a broad range of extramural research programs through contracts, grants, or cooperative agreements. Proposals can be submitted through the USAMRDC Broad Agency Announcement (BAA) or through special USAMRDC BAA Announcements, which are open for limited timeframes. Additional information, the USAMRDC Broad Agency Announcement, and open special USAMRDC BAA Announcements can be obtained at:  https://www.usamraa.army.mil/Pages/BAA.aspx and https://www.grants.gov/web/grants/view-opportunity.html?oppId=297726

U.S. Air Force/AFRL - 711 HPW BAA: The Airman Readiness Medical Research (ARMR) Hybrid Broad Area Announcement (BAA) was released May 1, 2020, and will remain open for 72 months for medical research to optimize the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective aims to: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

             See:  https://beta.sam.gov/opp/31a536d407cd4d519fc89ffd3366cbb3/view?keywords=AirmanReadinessMedicalResearch(ARMR)&sort=relevance&index=&is_active=true&page=1

      

U.S. Air Force/AFRL - BAA-AFRL-RQKHC-2016-0009 Aerospace Medicine, Clinical Research, Human Performance Research, and Expeditionary Medicine: This BAA will remain open for seventy-two (72) months with calls being released throughout the seventy-two (72) month period of performance.  The Air Force Research Laboratory (AFRL) 711 Human Performance Wing in the School of Aerospace Medicine and Human Systems Integration Directorate solicits innovative research proposals in the following five research areas.
1. Force Health Protection – Focus on research to prevent injury and illness and the early recognition or detection of emerging threats. 2. EN Route Care –Continuum of care during transport of patients from point of injury to point of definitive care.
3. Operational Medicine (OM) – Air Force Medical Service (AFMS) sponsored OM encompasses interest in definitive diagnosis, care, and treatment in-garrison, to ensure the highest quality of healthcare for active duty members and their families.
4. Expeditionary Medicine - Improving expeditionary medical care during contingency operations including medical countermeasures against combat and operational stressors to maximize warrior health, performance, and well-being.
5. Human Performance and Systems Integration - Maximizing operational human performance for a fit and healthy force.

             See: https://beta.sam.gov/opp/4eebfe8f580a41e8a32ba4eae5920342/view?keywords=AerospaceMedicine,ClinicalResearch,HumanPerformanceResearch,andExpeditionaryMedicine&sort=-relevance&index=&is_active=true&page=1

 

U.S. Military Academy Broad Agency Announcement - W911NF-20-S-0008: This BAA was released April 1, 2020, and is open until March 31, 2025. It seeks proposals for cutting- edge innovative research that could produce discoveries with significant impact to enable new and improved Army technologies and related operational capabilities in the areas of socio-cultural; information technology; ballistics, weapons and protections; energy and sustainability; materials, measurements, and facilities; unmanned systems and space; human support systems; and artificial intelligence, machine learning, and quantum technologies. The human support systems focus includes biomechanical engineering to enhance soldier readiness (human performance optimization, injury prediction/prevention, physical and cognitive augmentation, Return-to-Duty metrics, functional influence of prosthetics/exoskeletal devices) and wearable technologies and sensors to inform performance decisions (e.g., monitoring/assessment, injury prevention, recovery times). 

              See:  Military Academy BAA

Candidate Acute Traumatic Brain Injury (TBI) Management Capabilities (CATMC) and Acute TBI Diagnostics and Monitoring (ATDM) in Austere Environments

MTEC-20-15-TBI: Candidate Acute Traumatic Brain Injury (TBI) Management Capabilities (CATMC) and 
Acute TBI Diagnostics and Monitoring (ATDM) in Austere Environments
 
Medical Technology Enterprise Consortium (MTEC)/U.S. Government (USG) Department of Defense (DoD)
 
Description: This Request for Project Proposals (RPP) focuses on supporting acute diagnostic, 
therapeutic and management technologies across the spectrum of traumatic brain injury (TBI) 
severities capable of being  used  in  a  far-forward  operational  environment.  To  meet  the  
intent  of  this  RPP,  each  Solution Brief MUST specifically address only ONE of the two Focus 
Areas described:
 
•     FOCUS AREA #1 (Treatments): Development of an acute treatment (pharmaceutical, technology, 
etc.) for TBI.
 
•     FOCUS AREA #2 (Diagnostics): Diagnostic, prognostic and management technologies for acute, 
early intervention for TBI.
 
Offerors should only propose technology solutions that meet the following two criteria:
 
1.     Currently be at TRL 4 or 5 [definition of TRLs – https://mtec-sc.org/wp- 
 
2.     Currently be in development or commercially available.
 
The goal of this program is to fund projects to complete technology readiness level (TRL) 6.
 
Each MTEC Solution Brief submitted must be in accordance with the mandatory format provided in the 
MTEC PPG, which is available on the Members-Only MTEC website at www.mtec-sc.org. White papers are 
not required for this RPP.
 
MTEC will host a Proposers Conference within two weeks after the release of the RPP that will be 
conducted via webinar. Further instructions will be forthcoming via email. Offerors are advised to 
check the MTEC website periodically during the proposal preparation period for any clarifications 
found in Frequently Asked Questions (FAQ) responses.
 
Proposals due: September 1, 2020
 
Base period of performance (PoP1) up to 24 months (18 months or less is preferable)
 
Maximum amount: $2 million (projects to achieve TRL 5), $3 million (to achieve TRL 6)
 
 
Inquiries:
 
•     Contractual/cost/pricing - MTEC Contracts Administrator, mtec-contracts@ati.org
 
•     Technical/membership questions – Dr. Lauren Palestrini, lauren.palestrini@officer.mtec-sc.org
 
•     Administrative questions – Ms. Kathy Zolman, kathy.zolman@ati.org
 

Combat Readiness – Medical Research Program Rapid Development and Translational Research Award

W81XWH-20-S-CRRP: Combat Readiness – Medical Research Program Rapid
 
Development and Translational Research Award
 
Description: The FY20 Defense Appropriations Act provides funding to the Department of Defense 
Combat Readiness – Medical Research Program (CRRP) to support military-relevant advanced technology 
and therapeutic research related to forward-deployable solutions that can promptly address 
life-threatening injuries, medical threats, and treatments for Service members in current and 
future battlefield settings.  The managing agent for the anticipated Broad Agency 
Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) 
at the U.S. Army Medical Research and Development Command (USAMRDC).
 
The FY20 CRRP solicits research applications addressing at least one of six Focus Areas, which 
broadly describe current needs to ensure readiness for delivering front-line care in combat 
situations and for delivering medical damage control capability, assets, and lifesaving 
interventions to address the emerging needs of the Warfighter and Service medics during prolonged 
and en route care in austere and combat environments, including the acute and early management of 
combat-related trauma at the  point of injury. Focus Areas include:
 
•     Solutions for assessment of mild traumatic brain injury in deployed and far-forward settings 
to include portable devices
 
•     Enhanced delivery and utilization of telemedicine platforms Pre-proposals are required; 
application submission is by invitation only.
 
Award mechanism: Rapid Development and Translational Research Award
•     Supports research that will accelerate the movement of promising ideas into clinical 
applications, including healthcare products, technologies, and/or practice guidelines.
•     Preclinical research, including animal studies, that is already supported by substantial 
preliminary or published data and strongly validates clinical translation is appropriate.
•     Research involving human subjects and human anatomical substances is permitted; however, 
clinical trials are not allowed.
 
Pre-proposal deadline: September 10, 2020
Proposal/application deadline: December 3, 2020
Maximum funding: $2,000,000
Maximum period of performance: 2 years
 

NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders

NOT-DC-20-008: NIDCD is Interested in Supporting Research on the Impact of

COVID-19 on Mission Specific Sensory and Communication Disorders

 

Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other

Communication Disorders (NIDCD) (see: https://grants.nih.gov/grants/guide/notice-files/NOT-DC20-008.html)

 

NIDCD invites applications for research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech, and language. Given the early stage of COVID19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models. Areas of research encouraged through this NOSI include, but are not limited to:

 

  • Short- and long-term effects of COVID-19 on the auditory, vestibular, or olfactory systems
  • The prevalence, onset, and resolution of acquired deficits (i.e. HBTSVSL) among patients

    with COVID-19 across the lifespan and in association with various underlying genetic predispositions and health conditions

  • Potential ototoxicity from therapeutics or vaccination related to COVID-19
  • Worsening of communicative function because of physical distancing, sheltering in place,

    and wearing of protective personal equipment during mitigation of this infectious pandemic

  • Telehealth service delivery to individuals with communication disorders
  • Multidisciplinary collaborative teams including clinicians, basic biologists, geneticists,
    quantitative scientist, epidemiologists, or other researchers to study COVID-19 related
    human conditions and behaviors, bioethical considerations, health-service delivery,
    health services in low-resource areas, and health disparities within NIDCD mission areas

 

This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022. Submit applications for this initiative using one of the following funding opportunity announcements or any reissues of these announcement through the expiration date of this notice: PA-18-334, PA-20-185, PA-20-184, PA-20-196, PA-20-195, PA-20-194, PA-19-270, PA-19-271, PA-19-273, PA-19-272.

 

For funding consideration, applicants must include “NOT-DC-20-008” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

 

Scientific/Research Contact:

 

Bracie Watson, Jr. Ph.D.

NIDCD/Division of Scientific Programs

Telephone: 301-402-3458

Email: watsonb@nidcd.nih.gov

Improving Outcomes for Disorders of Human Communication Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD)

NOT-DC-20-007: Improving Outcomes for Disorders of Human Communication

Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other

Communication Disorders (NIDCD) (see: https://grants.nih.gov/grants/guide/notice-files/NOTDC-20-007.html)


This NOSI seeks to encourage effectiveness and health services research for improved

outcomes in the prevention and treatment of disorders of hearing, balance, smell, taste, voice,

speech, and language.

 

NIDCD effectiveness research seeks to measure, evaluate, and/or improve patient-centered

outcomes following intervention for communication disorders. Effectiveness research seeks to

determine to what degree an intervention works in patients/populations in general, real-world

settings, such as in diverse populations and diverse provider and clinical practice settings.

 

Health Services Research examines the impact of the organization, financing, and management

of health care services on the delivery, quality, cost, access to and outcomes of such services,

including demographic, social, economic, and health system factors as they relate to providing

preventive, screening, diagnostic, treatment and rehabilitative services and patient outcomes

of care. Research may focus on any/all of the different factors that impact access, utilization,

and quality as related to outcomes of health care services.

 

Applicants are encouraged to create collaborative teams which may include clinical experts not

only in the traditional NIDCD mission areas, but also in other medical specialties and health care

professions as well as experts in sociology, health services, health outcomes, economics,

biostatistics, public health, health care financing and organization, survey research,

psychometrics, epidemiology, and evaluation.

 

This notice applies to due dates on or after June 16, 2020 and subsequent receipt dates

through January 10 2022. Submit applications for this initiative using one of the following

funding opportunity announcements (FOAs) or any reissues of these announcement through

the expiration date of this notice: PA-18-334, PA-20-185, PA-20-184, PA-20-195, PA-20-194,

PAR-18-340, PA-19-272, PA-19-270, PA-19-273, PA-19-271.

 

For funding consideration, applicants must include “NOT-DC-20-007” (without quotation marks)

in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this

information in box 4B will not be considered for this initiative. For due dates after May 25,

2020, applicants must use "FORMS-F".

 

Scientific/Research Contact:

 

Kelly King, Au.D, Ph.D.

NIDCD/Division of Scientific Programs

Telephone: 301-402-3458

Email: kingke@nidcd.nih.gov

Dod hearing restoration focused research award

W81XWH-20-HRRP-FRA – DoD Hearing Restoration Focused Research Award
 
Description: The FY20 HRRP FRA mechanism supports promising research to accelerate drug discovery 
and therapeutic development for hearing restoration or accelerate advances in the assessment, 
diagnosis, and treatment of auditory dysfunction. Applications involving multidisciplinary 
collaborations among academia, industry, the military Services, the VA, and other Federal 
Government agencies are highly encouraged.
 
The HRRP will fund innovative research that has the potential to maximize operational performance, 
medical readiness, and quality of life for Service members, Veterans, and others living with 
significant auditory system injuries. Tinnitus or vestibular-related research is excluded. All 
applications to the FY20 HRRP FRA must address research in one or more of the following Focus 
Areas:
 
• Accelerate translation of biological regeneration/repair mechanisms into therapies that treat 
auditory system injury and restore auditory function. For example:
o Hair cell  regeneration/repair/recovery
o Neural  regeneration/repair/recovery
o Treatment for synaptopathy and hidden hearing loss
• Diagnostic tests that help differentiate sensory, neural, synaptic, and central processing 
disorders, that may inform applicability and outcomes for current or future hearing restoration 
therapeutics.
• Develop reliable in-vitro human models to facilitate the understanding, derivation, and 
characterization of human auditory cells, and/or to facilitate the evaluation of hearing 
restoration therapies.
• Develop and/or validate techniques/methods beyond the audiogram to diagnose acute auditory system 
injury in austere or remote environments. For example, but not limited to, simple and rapid 
assessments that are compatible with portable platforms.
 
Funding Level 1 supports exploratory, high-risk/high-reward research that is in the earliest stages 
of idea development. Research must have the potential to yield new avenues of investigation, such 
as new approaches, new research tools, or new paradigms.
 
Funding Level 2 supports the advancement of more mature research toward clinical translation.
Pre-app due: 14 July 2020
Full app due: 3 November 2020
Period of Performance: 2 years (Level 1), 3 years (Level 2)
Max Funding: $250,000 (Level 1), $1M-$1.25M (Level 2)
 

Advancing research to develop improved measures and methods for understanding multimorbidity (r01 clinical trial optional)

Description: This Funding Opportunity Announcement (FOA) invites applications that seek to improve 
the availability, quality, and utility of data and measures that capture multimorbidity or multiple 
chronic conditions (MCCs) and the methods for analyzing multimorbidity data.
Research supported by this initiative should be designed to discover, develop, and/or evaluate MCC 
measures/tools that reflect the longitudinality and life course diversity of multimorbidity. 
Multimorbidity may include physical health conditions, mental health conditions, or a combination 
of both. Priority areas include:
 
National Institute on Deafness and Other Communication Disorders (NIDCD)
The National Institute on Deafness and Other Communication Disorders (NIDCD) welcomes applications 
in which disordered communication processes, including diseases or conditions affecting hearing, 
balance, taste, smell, voice, speech, and language, are a component of the MCCs being examined. 
Populations of interest include both pediatric and adult. Examples include, but are not limited to:
 
• Development and validation of new approaches to measure hearing, vestibular, or chemosensory 
deficits in older adults with MCCs, including cognitive impairment.
• Normative data from existing tools across populations with communication disorders and MCCs, 
including populations that are underserved.
• New approaches to assessing risk for the communication disorder contributing to the development 
of other disorders/deficits/conditions.
 
Prospective applicants whose research interests relate to studies that identify shared mechanisms 
or development of innovative interventions to address MCCs should see PAR-20- 180.
 
Open Date (Earliest Submission Date): September 05, 2020
Application Due Date(s): October 05, 2020.
 
Expiration Date: September 08, 2023
 
Maximum Project Period: 5 years
Amount: “Applicants requesting $500,000 or more in direct costs in any year … must contact a 
Scientific/Research Contact at least 6 weeks before submitting the application….”

 

 

fy21 joint incentive fund(JIF): fy21 Request for JIF proposals

FY21 Joint Incentive Fund:FY21 Request for Joint Incentive Fund (JIF) Proposals

Description:FY 2021 JIF program cycle are now being accepted. Proposals that support creative coordination and sharing initiatives at the facility, intraregional, and nationwide levels will be considered. The proposals should have a goal of improving the access to, and quality and cost effectiveness of the health care provided by the Veterans Health Administration (VHA) and the Military Health System (MHS) to the beneficiaries of both Departments. Projects should be innovative DoD/VA joint sharing initiatives designated for use by the Veterans Health Administration (VHA) and the Military Health System (MHS) or for services or systems that facilitate Department of Veterans Affairs (VA) and the Department of Defense (DoD):

*             Interoperability

*             Recapture purchased care

*             Improve quality

*             Drive cost savings at facilities

JIF funds should not be used: to hire military personnel, for major construction or IT systems, to recover patient reimbursement costs, or for project sustainment purposes.

*             Submit signed final proposals electronically to Ms. Catherine Simpson (catherine.a.simpson.civ@mail.mil) and Mr. Michael Gardner (michael.gardner2@va.gov). Include in the submission a business case template and accompanying spend plan spreadsheet. Additional supporting documents may be attached as necessary.

*             DoD Only: Enter all signed final proposals into the MHS Request Submissions Portal at https://info.health.mil/SitePages/mhsCAR_submit.aspx for Defense Health Agency (DHA) review and DHA Director signature. Please reference the JIF Submission Instructions on how to submit JIF Proposals to DHA.

*             VHA Only: Please visit MAX.gov for more information about the JIF program at https://login.max.gov/cas/login?bypassMaxsso=true. Please contact Mr. Gardner for access.

               Proposals due: August 31, 2020

                Maximum period of performance: 2 years             

For more information, see: https://www.va.gov/VADODHEALTH/Joint_Incentive_Fund_JIF.asp

Questions: Ms. Catherine Simpson at (703) 275-6073,catherine.a.simpson.civ@mail.mil

Central and peripheral control of balance in older adults (r01 clinical trial optional)

RFA-AG-21-011: Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional)

NIH - National Institute on Aging (NIA) and National Institute on Deafness and Other Communication Disorders (NIDCD)

Description: This Funding Opportunity Announcement invites applications that propose basic and/or clinical studies to investigate central and peripheral control of balance in older adults and/or in 
relevant animal models. Given the multifactorial nature of balance, a team science approach is highly encouraged. Thus, applications should include collaborations across various disciplines 
relevant to balance (e.g. gerontology, neurology, neuroscience, audiology, otolaryngology, physical therapy, biomechanics, and/or biophysics).  Possible research studies of interest may include:

• Conducting population-based studies to understand the genetic, physiologic, neuromotor, 
behavioral, cognitive, emotional, and environmental factors that contribute to balance disorders
• Using technologies (e.g. brain stimulation, wearable sensors, virtual reality, real-time 
biofeedback) to better understand, diagnose, monitor, and/or intervene on the central and 
peripheral balance system
• Exploring the potential for use of innovative treatments (e.g. gene therapy, vestibular implants 
and prostheses) for vestibular impairment and balance disorders

Open Date (Earliest Submission Date): September 02, 2020

Application Due Date(s): October 02, 2020
Maximum Project Period: 5 years

Maximum Amount: $500,000/year
Additional Information:
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-011.html

 

Engineering Next-Generation Human nervous System Microphysiological systems (clinical Trials not allowed)

Description: This Funding Opportunity Announcement (FOA) encourages research grant applications 
directed toward developing next-generation human cell-derived microphysiological systems (MPS) and 
related assays that replicate complex nervous system architectures and physiology with improved 
fidelity over current capabilities. The purpose of this FOA is to stimulate basic 
technology-focused research to develop next-generation human cell-derived microphysiological 
systems (MPS) and related assays with improved fidelity to complex human brain, spinal cord, and/or 
sensory end organ circuit physiology, which will ultimately facilitate analysis of higher order 
functional deficits relevant to complex nervous system diseases.

This FOA encourages innovative approaches that are first-in-class, those that propose to 
substantially exceed the state of the art in tissue organization and function. These can be high 
risk, high impact designs. Additionally, this FOA encourages approaches that aim to improve 
robustness and reproducibility of physiologically relevant circuit or supportive systems-level 
measures.

PAR-20-055: R01 Research Project Grant – this mechanism is intended to provide support for the 
further development of projects where preliminary data supports the feasibility of the line of 
investigation. Applicants without preliminary data may wish to apply to the companion R21 FOA.

PAR-20-082: R21 Exploratory/Developmental Research Grant – this grant mechanism is intended to 
encourage exploratory/developmental research by providing support for the early and conceptual 
stages of project development. High risk/high reward projects that lack preliminary data may be 
most appropriate for this FOA. Applicants with preliminary data may wish to apply to the companion 
R01 mechanism.

NIH Institutes and Centers participating in this FOA have specific interests and priorities, 
including:

National Institute on Deafness and Other Communication Disorders (NIDCD)
• The institute is interested in a broad variety of approaches and technology/methodology 
development. Some examples, but not limited to, would be technical development of microarchitecture 
reagents including appropriate buffers, media, polymers and synthetics to generate improved 3D 
platforms and microenvironments to facilitate cellular attachment, proliferation, in areas of 
differentiation or regeneration of taste buds, hearing/balance sensory epithelium, or vocal folds; 
experimental improvements of drug assessment studies, high throughput replication and comparative 
analyses of laryngeal, chemosensory and auditory/vestibular function (e.g., ototoxicity, noise or 
drug trauma, and age-related sensory loss); experimental improvements to implantable chip or scaffold-derived

 

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (r01 basic experimental studies with humans required

PAR-19-384: Research on biopsychosocial factors of social connectedness and isolation on health, 
wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required
Description: This funding opportunity announcement (FOA) invites research projects that seek to 
explain the underlying mechanisms, processes, and trajectories of social relationships and how 
these factors affect outcomes in human health, illness, recovery, and overall wellbeing.
Types of projects submitted under this FOA include studies that prospectively assign human 
participants to conditions (i.e., experimentally manipulate independent variables) and that assess 
biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena 
related to social connectedness and isolatedness.

Applications submitted cannot include any specific aims that propose to measure clinical efficacy 
or effectiveness of any intervention. Investigators who wish to conduct studies with clinical 
endpoints as the primary outcomes should consider other NIH FOAs.

NIH Institutes and Centers participating in this FOA have specific interests and priorities, 
including:

National Institute on Deafness and Other Communication Disorders (NIDCD)
• Social connection and isolation across the lifespan in people with communication disorders
• NIDCD will accept applications when/if including human participants living with disorders of 
hearing, balance/vestibular, voice, speech, language, taste and smell.
•    Contact: Lana Shekim, PhD
National Institute on Deafness and Communication Disorders (NIDCD) Telephone: 301-496-5061
Email: shekiml@nidcd.nih.gov
Open Date (Earliest Submission Date): February 17, 2020
Application Due Date(s): March 17, 2020; March 17, 2021
Expiration Date: March 18, 2021

Maximum Project Period: 5 years
Amount: must reflect actual needs of the proposed project
Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-384.html
 

American Otological Society Research Foundation

If you would like to submit a grant for consideration of funding in 2020-2021, a LETTER OF INTENT and BIOSKETCH, including details regarding other existing support, must be submitted by November 1st of the year prior to funding. The next funding cycle begins July 1, 2020. The letter of intent must state the desired grant mechanism for the proposal (CSA, Fellowship grant, Research Grant), the Principal Investigator and Institution(s), a working title and abstract and include Specific Aims and a proposal summary (2 page limit on abstract and aims).

Find more information at: https://www.americanotologicalsociety.org/aos-grant-submission-instructions  

Army Research Office Broad Agency Announcement for Fundamental Research

Announcement: Funding

Title:  ARMY RESEARCH OFFICE BROAD AGENCY ANNOUNCEMENT FOR FUNDAMENTAL RESEARCH

Type/Mechanism: Grant
Funding Opportunity Number: 
W911NF-17-S-0002-04

Application Open:  1 April, 2017 – 31 March 2022

Notes:  (See below for additional info)

Description: ARO is focused exclusively on extramural basic research, and is responsible for the vast majority of ARL’s extramural research programs and funding. Competencies are structured to create discovery, innovation, and transition of technologies leading to Power Projection Superiority, Information Supremacy, Lethality and Protection Superiority, and Soldier Performance Augmentation for Strategic Land Power Dominance. Proposals are expected to be for cutting-edge innovative research that could produce discoveries that would have a significant impact on enabling new and improved Army operational capabilities and related technologies. Specific research areas and topics of interest should be viewed as suggestive, rather than limiting. ARO is always interested in considering new innovative research concepts of relevance to the Army. Additional information about ARO areas of interest can be found on the ARL website:

http://www.arl.army.mil/www/default.cfm?page=29.

Research areas of interest include

·        Life Sciences (Neurophysiology of Cognition/Multisensory Synthesis)

·        Intelligent Systems for Improved Decision Making (sensing, perception, situation awareness)

·        Biomathematics (modeling sensory processing, disease processes)

·        International Opportunities: Human Dimension, Big Data

This Funding Opportunity Announcement is a BAA. It is continuously open for a 5-year period, from 01 April 2017 closing 31 March 2022. Proposals will be considered until and including the closing date of this announcement.

There are no specific funding restrictions associated with this BAA. The proposed duration for which support is requested should be consistent with the nature and complexity of the proposed activity.

For more information, https://www.grants.gov/web/grants/view-opportunity.html?oppId=292877

NIDCD Clinical Research Center Grant (P50/Clinical Trial Optional)

Announcement: Grant
Title:  NIDCD Clinical Research Center Grant (P50/Clinical Trial Optional)
Award Organization: NICD
Type/Mechanism: Grant
Funding Opportunity Number: PAR-19-137
Award Amount: $1.5M/year 
Pre-proposals Due:  7 Jan, 2019
Full App Due: February 6, 2019; June 6, 2019; October 4, 2019; February 6, 2020; June 8, 2020; October 6, 2020; February 8, 2021; June 6, 2021; October 6, 2021


Notes: 
Description: The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders.  For this announcement, Clinical Research is defined as research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. Examples of such research include but are not limited to, studies of the prevention, pathogenesis, pathophysiology, diagnosis, treatment, management or epidemiology of a disease or disorder of hearing, balance, smell, taste, voice, speech, or language.

Applications may propose a clinical trial but are not required (optional).  

Proposed research must meet 4 essential criteria:

1.  Must be clinical as defined above.
2.  Must have a well-defined central unifying theme consisting of three or more research projects with 1 or more supporting cores as appropriate; one core must be an administrative core.
3.  Each project must be unambiguously related to the central unifying theme. Synergistic and substantial interactions among the projects should be evident.
4.  Must provide multidisciplinary approaches to the central theme, defined as having research projects representing different disciplines, approaches and expertise. 

Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-137.html

 

broad agency announcement (baa) for extramural biomedical research and development

Announcement: Grant
Title:  BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development
Award Organization: USSOCOM 
Type/Mechanism: Grant
Funding Opportunity Number: W81XWH-18-S-SOC1
Web Site: DoD : https://www.grants.gov/web/grants/view-opportunity.html?oppId=307754 
Expected Number of Awards: 2
Period of Performance:  2 years
Open App: 1 Aug 2018
Close App: 31 Jul 2023
Description: A primary emphasis of the USSOCOM Biomedical, Human Performance, and Canine Research Program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care (PFC), human performance optimization, and canine medicine/performance. Special Operations Forces (SOF) medical personnel place a premium on medical equipment that is small, lightweight, ruggedized, modular, multi-use, and designed for operation in extreme environments. The equipment must be easy to use, require minimum maintenance, and have low power consumption. Drugs and biologics should not require refrigeration or other special handling. All materiel and related techniques must be simple and effective, and easily modified for commercialization. 

Research areas of interest include:

• Canine Medicine: 
o Sensory Optimization and Protection: The proposed project must develop research oriented toward innovative methods that enhance or conserve SOF canine olfactory, visual, and/or auditory performance during combat operations.

Max Funding: Most projects are anticipated to have a total cost at or below $700,000 (including indirect costs). Projects that have a total cost higher than $700,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $1,500,000 (including Indirect costs). No budget will be approved by the Government exceeding $1,500,000 (including indirect costs).

Brain initiative

Announcement: RFA-NS-18-030
Award Organization: National Institute of Health (NIH)
Type/Mechanism:  Reissue of RFA-NS-18-009
Activity Code: R01 Research Project Grant
Web Site: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-030.html
Award Amount: Max funding: $15M to fund 20 awards
PoP: Up to 5 years
Restrictions: 
Pre-Application Due: Earliest Submission Date: 3 June 2018
Application Due Dates: 6 Novemebr 2018; 3 July 2019; 1 July 2020; 10 November 2020
 Notes: The primary goal of this FOA is to solicit research projects using innovative, methodologically-integrated approaches to understand how circuit activity gives rise to mental experience and behavior.  The activity of neural circuits is the substrate of cognitive processes such as perception, attention, reasoning, intention, decision-making, and emotion. These internal activities are translated into patterns of activation that support simple motor behaviors, as well as more complex behaviors such as navigation and communication. Dysfunction of these large systems of neurons due to disease, injury, or developmental anomaly is the basis of neural and mental disorders. A mission of the NIH BRAIN Initiative is to understand how large scale neural systems contribute to cognitive and neurological function in both health and disease.

                                 

improving outcomes for disorders of human COMMUNICATIONS

NOT-DC-20-007: Improving Outcomes for Disorders of Human Communication

Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other 
Communication Disorders (NIDCD) (see: https://grants.nih.gov/grants/guide/notice-files/NOT- 
DC-20-007.html)

This NOSI seeks to encourage effectiveness and health services research for improved outcomes in 
the prevention and treatment of disorders of hearing, balance, smell, taste, voice, speech, and 
language.

NIDCD effectiveness research seeks to measure, evaluate, and/or improve patient-centered outcomes 
following intervention for communication disorders. Effectiveness research seeks to determine to 
what degree an intervention works in patients/populations in general, real-world settings, such as 
in diverse populations and diverse provider and clinical practice settings.

Health Services Research examines the impact of the organization, financing, and management of 
health care services on the delivery, quality, cost, access to and outcomes of such services, 
including demographic, social, economic, and health system factors as they relate to providing 
preventive, screening, diagnostic, treatment and rehabilitative services and patient outcomes of 
care. Research may focus on any/all of the different factors that impact access, utilization, and 
quality as related to outcomes of health care services.

Applicants are encouraged to create collaborative teams which may include clinical experts not only 
in the traditional NIDCD mission areas, but also in other medical specialties and health care 
professions as well as experts in sociology, health services, health outcomes, economics, 
biostatistics, public health, health care financing and organization, survey research, 
psychometrics, epidemiology, and evaluation.

This notice applies to due dates on or after June 16, 2020 and subsequent receipt dates through 
January 10 2022. Submit applications for this initiative using one of the following funding 
opportunity announcements (FOAs) or any reissues of these announcement through the expiration date 
of this notice: PA-18-334, PA-20-185, PA-20-184, PA-20-195, PA-20-194, PAR-18-340, PA-19-272, 
PA-19-270, PA-19-273, PA-19-271.

For funding consideration, applicants must include “NOT-DC-20-007” (without quotation marks) in the 
Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this 
information in box 4B will not be considered for this initiative. For due dates after May 25, 2020, 
applicants must use "FORMS-F".

Scientific/Research Contact:

Kelly King, Au.D, Ph.D. NIDCD/Division of Scientific Programs Telephone: 301-402-3458

Email: kingke@nidcd.nih.gov

Research Interests of the Air Force Office of Scientific Research

Announcement: BAA-AFRL-AFOSR-2016-0007
Award Organization: Air Force Office of Scientific Research
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD: http://www.grants.gov/web/grants/view-opportunity.html?oppId=285269
Award Amount: $200,000 - $400,000 encouraged; $7.5M max
PoP: 5 years
Restrictions: None
Rolling Annual Programs: Open until Superseded
Pre-Application Due: Open until superseded
Full App Due: Open until superseded
Notes: For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources.

AFOSR - Chemistry and Biological Sciences -Human Performance and Biosystems

Announcement: Human Performance and Biosystems
Award Organization: AFRL
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD: http://www.wpafb.af.mil/Welcome/Fact-Sheets/Display/Article/842038#anchor2
Award Amount: Contact Program Officer Dr. Patrick O. Bradshaw 703-588-8492
PoP: 3-5 years 
Restrictions: See site
Rolling Annual Programs: 
Pre-Application Due:
 Contact Program Officer Dr. Patrick O. Bradshaw 703-588-8492
Full App Due:Contact Program Officer Dr. Patrick O. Bradshaw 703-588-8492
Notes: The primary goal for this program is to gain a better understanding of the biophysical, biochemical, and physiological mechanisms responsible for the behavioral, genetic, cellular, tissue and systems changes resulting from various forms of bio-stimulation. Additionally, a sensory systems focus has been added to this program and the emphasis is on developing the basic scientific foundation to understand and emulate sensory information systems. Emphasis is on (a) acoustic information analysis, especially in relation to human auditory perception, and (b) sensory and sensorimotor systems that enable 3D airborne navigation and control of natural flight, e.g., in insects or bats, especially in relation to capabilities of autonomous biological systems not yet emulated in engineered flight.  For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources. Signal analysis methods based upon purely statistical or other conventional "blind source" approaches are not as likely to receive support as approaches based upon auditory system concepts that emphasize higher-level neural processes not yet fully exploited in engineered algorithms for acoustic information processing. Applicants are encouraged to develop collaborative relationships with scientists in the Air Force Research Laboratory (AFRL).

DOD USAMRMC FY18-FY22 Broad agency announcement for extramural medical research

Announcement: W81XWH18SBAA1
Award Organization: U.S. Army Medical Research and Material Commnad's
Type/Mechanism: Grants Notice
Activity Code: USC, Title 10, Section 2358
Web Site: https://www.grants.gov/web/grants/search-grants.html?keywords=W81XWH18SBAA1
Award Amount:  
PoP: 4 years 
Restrictions: 
Rolling Annual Programs:
Pre-Application Due: Oct 1, 2017
Full Application Due :  September 30, 2022, 11:59 p.m. ET
Notes: Clinical and Rehabilitative Medicine Research Program focus on the innovations required to reset our wounded Service members, both in terms of duty performance and quality of life. Innovations developed from CRMRP-supported research efforts are expected to improve restorative treatments and rehabilitative care to maximize function for return to duty (RTD) or civilian life. 
The CRMRP focuses its efforts on the following research areas: neuromusculoskeletal injury (including limb trauma and amputation), sensory systems impairment (including hearing, balance, tinnitus, and vision), acute and chronic pain, and regenerative medicine.

Quick Fact

#17

Any exposure to 140 dB sound (e.g., gun shot or a firecracker) can cause immediate damage and actual pain.

About Us

The Hearing Center of Excellence fosters and promotes the prevention, diagnosis, mitigation, treatment, rehabilitation and research of hearing loss and auditory injury. It supports the development, exchange and adoption of best practices, research, measures of effectiveness and clinical care guidelines to reduce the prevalence and cost of hearing loss and tinnitus among Warriors and Veterans. Read more

Hearing Health Challenge For Change

Take the challenge, pledge your commitment, and share your story in the prevention of hearing loss in America today.

The Hearing Center of Excellence is committed to promoting Hearing Loss Programs and Hearing Loss Prevention Initiatives across the DoD. Take the pledge to implement the Comprehensive Hearing Health Program (CHHP) at your local clinic and share with us how it's going for you!

Pledge on Facebook Pledge on Twitter
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.